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Background: Sonoran ethnic groups (Yaquis, Mayos, Seris, Guarijíos, Pimas, Kikapúes and Pápagos) use mainly
herbal based preparations as their first line of medicinal treatment. Among the plants used are those with
anti-tuberculosis properties; however, no formal research is available.
Methods: Organic extracts were obtained from nine medicinal plants traditionally used by Sonoran ethnic groups
to treat different kinds of diseases; three of them are mainly used to treat tuberculosis. All of the extracts were
tested against Mycobacterium tuberculosis H37Rv using the Alamar Blue redox bioassay.
Results: Methanolic extracts from Ambrosia confertiflora, Ambrosia ambrosioides and Guaiacum coulteri showed
minimal inhibitory concentration (MIC) values of 200, 790 and 1000 μg/mL, respectively, whereas no effect was
observed with the rest of the methanolic extracts at the concentrations tested. Chloroform, dichloromethane, and
ethyl acetate extracts from Ambrosia confertiflora showed a MIC of 90, 120 and 160 μg/mL, respectively.
Conclusions: A. confertiflora and A. ambrosioides showed the best anti-mycobacterial activity in vitro. The activity of
Guaiacum coulteri is consistent with the traditional use by Sonoran ethnic groups as anti-tuberculosis agent.
For these reasons, it is important to investigate a broader spectrum of medicinal plants in order to find compounds
active against Mycobacterium tuberculosis.
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Tuberculosis (TB) is a chronic infectious disease caused
mainly by Mycobacterium tuberculosis [1,2]. The World
Health Organization (WHO) estimated that almost 9
million new cases and 1.4 million TB deaths (990 000
among HIV-negative people and 430 000 HIV-associated
TB deaths), occurred in 2011 [3]. Ninety-five percent of
TB cases are produced in underdeveloped countries,
80% of them corresponding to the 15 to 29-year-old
group, generating strong socioeconomic problems [4].
Furthermore, the lack of treatment adherence has given
rise to antibiotic-resistant M. tuberculosis strains. The* Correspondence: agaribay@guayacan.uson.mx
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distribution, and reproduction in any mediumresistance is classified into two groups: the multidrug-
resistant TB (MDR-TB), which does not respond to the
first-line standard treatment, and the extensively drug-
resistant TB (XDR-TB), which occurs when resistance to
second-line drugs develops [5]. According to the new
2012 WHO report on surveillance and response to
MDR-TB and XDR-TB, an estimate of 310 000 (range,
232 000–400 000) MDR-TB cases occurred among
recorded pulmonary TB patients in 2011, with 84 coun-
tries reporting at least one case of XDR-TB [3]. This
emphasizes the need to search for new drugs against
tuberculosis [6,7].
According to the National Epidemiological Surveillance
(SINAVE), Mexico has shown a reduction in TB incidence
and has been considered as a medium security risk region
by WHO. Nevertheless, 17 000 new cases and approxi-
mately 2000 deaths each year are reported in Mexico [8,9].Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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has one of the richest flora on the planet, compared with
that in Malaysia and some regions in central and South
America [10]. Sonora is located on the northwestern
region of Mexico and is the second largest state of the
country, characterized by more than 3000 plant species
widely known and used by the local ethnic groups: Yaquis,
Mayos, Seris, Guarijíos, Pimas, Kikapúes, and Pápagos
[11]. These groups use herbal remedies in their traditional
medicine for cultural reasons, as well as due to the in-
accessibility to medical services and/or their expectative of
resolving pathologies considered incurable or inoperable
by modern medicine [10,11]. Since no report exists yet on
studies showing the anti-tuberculosis activity of Sonoran
plants, the objective of the present research was to evalu-
ate the potential anti-mycobacterial activity of medicinal
plants used by the Sonoran ethnic groups for the treat-
ment of tuberculosis and other diseases.
Methods
Plants and extracts preparations
Plants collection
Nine plants were selected based on their traditional use
by Sonoran ethnic groups for tuberculosis or symptom-
related diseases, such as cough, fever, lack of appetite, and
weakness or caquexia (Table 1). Plants were collected from
wild environments located in the surrounding area of





















































Huizache, vinorama, Kuká Throat and digestive
cold, diarrhea, typho
spleen, weak heart,
headachecollected in a zone located 80 km South of Hermosillo; both
collecting areas belong to the Sonoran desert ecosystem [12].
The aerial parts, fruits, and/or flowers were obtained and
handled separately. The plants were authenticated at the
Herbarium of the University of Sonora by Professor Jesús
Sánchez-Escalante, where voucher specimens were deposited.Preparation of methanolic extracts of collected plants
One-hundred grams of dry samples were macerated and
kept in 1 L methanol at room temperature for one week,
with occasional stirring. Solids were filtered out and the
extracts concentrated by evaporation under reduced pres-
sure at 40°C in a Yamato RE300 rotator evaporator [13].
For their use in the susceptibility testing, working solu-
tions of the methanolic extracts were prepared in Mid-
dlebrook 7H9 broth containing 20% DMSO, at four times
the maximum desired testing concentration. All solutions
were sterilized by filtration through a 0.22-μm pore size
nitrocellulose membrane (Millipore). Final concentration
of DMSO in the assay was ≤5%, which does not produce
mycobacterial toxicity (internal control).Preparation of organic extracts of plants with
anti-mycobacterial activity
The plant whose methanolic extract exhibited anti-
mycobacterial activity at ≤ 200 μg/mL was further extracted
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Table 2 In vitro anti-mycobacterial activity of medicinal
plant’s methanol extracts




Ambrosia confertiflora DC. Aerial parts 200
Ambrosia ambrosioides (Cav.) W.W. Payne Aerial parts 790
Guaiacum coulteri A. Gray Flower 1000
Acalypha californica Benth. Aerial parts NI
Schinus molle L. Leaf NI
Fruit NI
Vallesia glabra Aerial parts NI
Baccharis salicifolia (Ruíz & Pavon) Pers. Aerial parts NI
Phoradendrom californicum Nutt. Aerial parts NI
Acacia farnesiana (L.) Wild Leaf NI
Fruit NI
Rifampicin 0.1171
MIC: minimal inhibitory concentration.
NI: no inhibition even at the highest concentration tested (1000 μg/mL).
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aration. This extraction was done non-sequentially.
Mycobacterium tuberculosis
Mycobacterium tuberculosis strain H37Rv (sensitive to
streptomycin, isoniazide, rifampicin, ethambutol, and
pyrazinamide) was provided by the Institute of Epide-
miological Diagnosis and Reference of the Mexican Ministry
ofHealth, andwas stored and handled at the State of Sonora’s
Public Health Laboratory.
Preparation of Mycobacterium tuberculosis inoculum
An initial inoculum was prepared from a solid M. tubercu-
losis culture, until it reached the log growth phase (approxi-
mately 12 days). The bacterium was then transferred to a
sterile vial containing five glass pearls (3 mm) and 8 mL of
sterile 0.85% saline solution. The bacterial suspension was
disaggregated by agitation using a Genie II vortex, and left
to stand for 15 min at room temperature. The supernatant
was then adjusted, using the 1 McFarland standard, to ob-
tain a bacterial concentration of 3.0 × 108 CFU/mL. The
working solution was a 1:25 dilution of this suspension, in
Middlebrook 7H9 broth supplemented with 0.2% (v/v)
glycerol and 10% (v/v) OADC (oleic acid, albumin, dex-
trose, and catalase enrichment; Becton Dickinson) for the
in vitro anti-mycobacterial activity assay.
In vitro anti-mycobacterial assay
To evaluate the activity of organic extracts, the redox
Alamar Blue® (AbD Serotec) microplate assay (MABA)
was carried out as described by Franzblau and collabora-
tors [14]. The assay was carried out on 96-well polystyr-
ene flat bottom plates with low evaporation cover lids,
in which the M. tuberculosis inoculum was added to
supplemented Middlebrook 7H9 broth medium, and
mixed with the extracts at different concentrations. In
order to prevent excessive evaporation, sterile distilled
water was added to the perimetral wells. Rifampicin
(Sigma Aldrich) was used as control. Next, 50 μL of fresh
Alamar Blue-10% Tween 80 (Sigma Aldrich) mixture (1:1)
were added to each well. The microplate was sealed
with parafilm and incubated for 48 hours at 37°C.
Finally, MIC was calculated and defined as the lowest
extract or antibiotic concentration at which no color
change of the indicator was evident. Each extract was
tested in triplicate.
Screening for sesquiterpene lactones
To search sesquiterpenes lactones in the extracts, the
Baljet reaction was used. A 1% picric acid (w/v) solution
in ethanol and a 10% sodium hydroxide (w/v) aqueous
solution were combined at a 1:1 ratio and added to 2–3 mg
of sample. A positive reaction was indicated by an orange
to red color change [15,16].Results and discussion
Plants used in the present study were selected according
to their traditional usage for the treatment of tubercu-
losis or symptom-related diseases by the Sonoran ethnic
groups. Table 1 shows the identification of the studied
plants, by scientific and common name, traditional use,
parts analyzed, and the ethnic group that uses them as
medicinal remedy. The extraction method was chosen
based on the consideration that methanolic extracts may
contain a wide range of chemical compounds with bio-
logical activity such as terpenoids, phenols, flavonoids,
saponines, steroids, and others [17-20]. In addition,
some studies have reported that methanolic extracts are
more active than aqueous extracts in their antibacterial
activity [21].
Table 2 shows the MIC values of methanolic extracts
of the plants studied. The methanolic extract from
Ambrosia confertiflora showed a MIC value of 200 μg/mL
against M. tuberculosis H37Rv. Methanolic extracts
from Ambrosia ambrosioides and Guaiacum coulteri
showed MICs of 790 and 1000 μg/mL, respectively. On
the other hand, the extracts from Acalypha californica,
Schinus molle, Vallesia glabra, Baccharis glutinosa,
Phoradendrom californicum and Acacia farnesiana did
not show inhibition even at the highest tested concen-
tration. Guaiacum coulteri, traditionally used against
tuberculosis by ethnics groups, resulted less effective
in vitro than A. confertiflora (which is not traditionally
indicated as anti-TB plant) in the anti-mycobacterial
assay. However, as we use only flowers from G. coulteri
for the anti-mycobacterial assay, it is important to
evaluate other parts of this plant to assess this activity.
Table 3 In vitro anti-mycobacterial activity results of
organic extracts obtained from Ambrosia confertiflora,
and sesquiterpene lactones status
Organic extracts MIC (μg/mL) Baljet reaction
Chloroform 90 +
Dichloromethane 120 +
Ethyl acetate 160 +
Methanol 200 +
Rifampicin 0.1171 ND
MIC: minimal inhibitory concentration; ND: Not determined; +: positive.
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groups to treat diseases with symptoms closely related
to tuberculosis, such as fever and lack of appetite
(Table 1), and furthermore, the family to which it be-
longs (Asteraceae) contains species with a high concen-
tration of sesquiterpene lactones (SQL) identified for
their wide variety of biological activities, including their
anti-mycobacterial effect [22,23]. Species of the genus
Ambrosia have been previously reported for their anti-
tuberculosis activity, associated to SQL [24]. It is likely
that the anti-tuberculosis activity observed in A. conferti-
flora and A. ambrosioides is associated with the presence
of such molecules.
Acacia farnesiana, G. coulteri, and S. molle have been
referred by Sonoran traditional medicine as anti-tubercular
agents, but only G. coulteri resulted active under the condi-
tions tested. In this study we used leaves and fruits
of A. farnesiana and S. molle to evaluate the anti-
mycobaterial activity which could explain our results, es-
pecially in the case of A. farnesiana from which several
products (gum, flower, seed, leaves, cortex, root) are used
by ethnias as anti-tubercular medicine.
With the exception of Schinus molle, none of the
plants studied had been evaluated before in Mexico for
their anti-tuberculosis properties [25]. Molina-Salinas
et al. [25] reported a MIC of 125 μg/mL for the hexane
extract of S. molle; however, for the methanolic extract
evaluated in the present study, no activity was detected
even at the highest concentration tested (1000 μg/mL).
The differences between the results obtained by Molina-
Salinas et al. [25] and ours are attributed to the presence
of mainly non-polar compounds in the hexane extract,
in contrast with the methanolic extract where high po-
larity compounds are present.
Diverse methods and procedures to assess anti-
mycobacterial agents are currently used, resulting in a
diversity of cut-off values to define a MIC value as
active: MIC ≤100 μg/mL, ≤125 μg/mL, ≤ 200 μg/mL
[6,25-27]. For this reason, no international standard has
yet been established to adequately define the level of
anti-mycobacterial activity. For the present study we de-
fined as active the extract with a MIC value of ≤ 200 μg/
mL, considering the presence of the active component
(s) at adequate concentration for their further isolation
and purification, such was the case of Ambrosia conferti-
flora methanolic extract.
References to medicinal plants used by ethnic groups
are mainly considered as a relevant guideline in the re-
search of natural products; however, in many cases it is
possible to validate the biological activity referred, but in
others it is not possible to confirm scientifically their
medicinal properties.
The difference in the anti-mycobacterial activity of
A. confertiflora, A. ambrosioides and G. coulteri may beattributed to the difference in the relative concentration
of the active compound in these plants. However, further
research is required to demonstrate this statement.
Several reports correlate the high content of terpenoid
compounds and different biological activities for the genus
Ambrosia, such as anti-fungal, anti-trypanosomic, and
anti-leishmania, as well as an anti-malaria effect [28-31].
From A. confertiflora, SQLs could be responsible for
the anti-mycobacterial effect observed in the present
study [32,33]. Cantrell et al. [23], in their review, re-
ported plant-derived terpenoids and some synthetic
analogs with variable anti-tubercular activity by the
BACTEC 460 system. Particularly, over 50 sesquiterpene
are reported [23] in that evaluation, where the most ac-
tive compounds from A. confertiflora were santamarine
and reynosin with a MIC value of 64 μg/mL. The MIC
values obtained in our study are higher in comparison
with those previously reported for reynosin and santa-
marine, since these are pure compounds, whereas ours
were crude extracts.
Based on the latter and considering that the SQLs iso-
lated by Yoshioka and collaborators are from a chloroform
extract [32], we included less polar crude extracts such as
chloroform, dichloromethane, and ethyl acetate from
A. confertiflora and evaluated the effect on the growth of
M. tuberculosis H37Rv. The results evidenced an increase
in the activity of these extracts in comparison to the meth-
anolic extract; but the main activity was obtained with
chloroform with a MIC value of 90 μg/mL. On the other
hand, the dichloromethane and ethyl acetate extracts
showed MIC values of 120 and 160 μg/mL, respectively
(Table 3). Highly polar molecules exhibit a reduced trans-
port through the outer lipid layer of mycobacteria and, in
consequence, lower anti-mycobacterial activity, whereas
less polar molecules exhibit higher permeability [34,35].
These reports are in agreement with our results, where the
extracts obtained with less polar solvents showed better
activity than those exhibited by the methanolic extracts.
Our findings reveal that the extraction method with
intermediate-polarity solvents (e.g. dichloromethane)
favors the possibility to obtain active compounds against
M. tuberculosis, since it would be quite difficult to
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reported by Camacho-Corona and collaborators [27];
hence, the active compounds against this pathogen must
be either less polar or even non-polar [25]. For this rea-
son, the aqueous extraction method would not be the
ideal method to obtain anti-mycobacterial compounds.
Based on studies reporting that both A. confertiflora
and A. ambrosioides are rich in SQLs [22,23], we chose
to perform a qualitative Baljet reaction to establish the
possible presence of these molecules, resulting positive
for all the different extracts (chloroform, dichlorometh-
ane, ethyl acetate and methanol) of A. confertiflora
(Table 3) and the methanolic extract from A. ambro-
sioides. Although this reaction is also positive for cardiac
glycosides and others containing α, β-unsaturated lac-
tones, anti-mycobacterial activity has been attributed to
this kind of molecules. Further studies are being
performed on A. confertiflora to isolate the active
compounds.Conclusions
Ambrosia confertiflora and A. ambrosioides were in-
cluded in this study, despite not being used for the treat-
ment of tuberculosis by local ethnic groups, and showed
the best anti-mycobacterial in vitro activity.
The anti-mycobacterial activity of Guaiacum coulteri
is consistent with the traditional use by Sonoran ethnic
groups as anti-tuberculosis agent.
However, in the case of Schinus molle and Acacia far-
nesiana which are used against tuberculosis by these
groups, no anti-mycobacterial activity was found, since
only leaves and fruits were evaluated, but not gum,
flower, seed, cortex or root as used by ethnias especially
in the case of A. farnesiana.
For these reasons it is important to investigate a
broader spectrum of medicinal plants in order to find
compounds active against Mycobacterium tuberculosis.
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